Rising prevalence of infectious diseases and collaborations and partnerships among market players for adjuvant vaccine development and increasing focus on...
/PRNewswire/ -- The "Idiopathic Pulmonary Fibrosis Treatment Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added...
Growth in a number of dialysis centers, increase in critical care admissions, presence of a large geriatric population, and government initiatives to...
Shares of Elicio to commence trading on Nasdaq under the ticker symbol “ELTX” on June 2, 2023First in human Phase 1 data on lead candidate ELI-002 to be...
Gainers Oncorus, Inc. (NASDAQ: ONCR) shares rose 90% to $0.38 in pre-market trading after dropping around 17% on Thursday. Oncorus recently posted a narrower-than-expected quarterly loss.
Chronic kidney disease (CKD) is a debilitating condition that affects people all over the world, and it is one of a small number of non-communicable...
BOSTON, May 01, 2023 (GLOBE NEWSWIRE) -- Elicio Therapeutics, a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and fast, with a skew ...